Alzamend Neuro Announces Date for Delivery of Topline Data for Phase 1 First-in-Human Clinical Trial for AL001 for Dementia Related to Alzheimer’s

VIEW NEWS ARCHIVE

Making Alzheimer's Just a Memory™

  • Alzamend Neuro is a registered mark of Alzamend Neuro Inc.
  • Copyright © 2016 - 2022 Alzamend Neuro Inc. All rights reserved.